Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 14, Issue 1, 2009, Pages 14-21

  Pirro, Matteo ^a   Schillaci, Giuseppe ^a   Romagno, Paolo F ^a   Mannarino, Massimo R ^a   Bagaglia, Francesco ^a   Razzi, Rolando ^a   Pasqualini, Leonella ^a   Vaudo, Gaetano ^a   Mannarino, Elmo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Endothelial dysfunction; Endothelial progenitor cells; Hypercholesterolemia; Statin

Indexed keywords

CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BRACHIAL ARTERY; CELL FUNCTION; CELL MOTILITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; LIPID ANALYSIS; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; STEM CELL; VASODILATATION;

CHOLESTEROL; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; FLUOROBENZENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PYRIMIDINES; STEM CELLS; SULFONAMIDES; TREATMENT OUTCOME; VASODILATION;

EID: 61449123110     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/1074248408331021     Document Type: Article

References (27)

1. Chen CH, Jiang T., Yang JH, et al. Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription. Circulation. 2003; 107: 2102-2108.
2. Maas R., Schwedhelm E., Kahl L., et al. Simultaneous assessment of endothelial function, nitric oxide synthase activity, nitric oxide-mediated signaling, and oxidative stress in individuals with and without hypercholesterolemia. Clin Chem. 2008; 54: 292-300.
3. Lupattelli G., Marchesi S., Roscini AR, et al. Direct association between high-density lipoprotein cholesterol and endothelial function in hyperlipemia. Am J Cardiol. 2002; 90: 648-650.
4. Xu Q. The impact of progenitor cells in atherosclerosis. Nat Clin Pract Cardiovasc Med. 2006; 3: 94-101.
5. Mannarino E., Pirro M. Endothelial injury and repair: a novel theory for atherosclerosis. Angiology. 2008; 59: 69S - 72S.
6. Pirro M., Schillaci G., Bagaglia F., et al. Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk. Atherosclerosis. 2008; 197: 757-767.
7. Hill JM, Zalos G., Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003; 348: 593-600.
8. Chen JZ, Zhang FR, Tao QM, Wang XX, Zhu JH, Zhu JH Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci (Lond). 2004; 107: 273-280.
9. Pirro M., Schillaci G., Paltriccia R., et al. Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2006; 26: 2530-2535.
10. Mohler ER 3rd, Fang Y., Shaffer RG, et al. Hypercholesterolemia suppresses Kir channels in porcine bone marrow progenitor cells in vivo. Biochem Biophys Res Commun. 2007; 358: 317-324.
11. Wassmann S., Werner N., Czech T., Nickenig G. Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ Res. 2006; 99: e74 - e83.
12. Op den Buijs J., Musters M., Verrips T., Post JA, Braam B., van Riel N. Mathematical modeling of vascular endothelial layer maintenance: the role of endothelial cell division, progenitor cell homing, and telomere shortening. Am J Physiol Heart Circ Physiol. 2004; 287: H2651 - H2658.
13. Chu K., Jung KH, Lee ST, et al. Circulating endothelial progenitor cells as a new marker of endothelial dysfunction or repair in acute stroke. Stroke. 2008; 39: 1441-1447.
14. Marchesi S., Lupattelli G., Siepi D., et al. Short-term atorvastatin treatment improves endothelial function in hypercholesterolemic women. J Cardiovasc Pharmacol. 2000; 36: 617-621.
15. Martínez-González J., Badimon L. Influence of statin use on endothelial function: from bench to clinics. Curr Pharm Des. 2007; 13: 1771-1786.
16. Tsiara S., Elisaf M., Mikhailidis DP Early vascular benefits of statin therapy. Curr Med Res Opin. 2003; 19: 540-556.
17. Vasa M., Fichtlscherer S., Adler K., et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation. 2001; 103: 2885-2890.
18. Deschaseaux F., Selmani Z., Falcoz PE, et al. Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors. Eur J Pharmacol. 2007; 562: 111-118.
19. Kusuyama T., Omura T., Nishiya D., et al. The effects of HMG-CoA reductase inhibitor on vascular progenitor cells. J Pharmacol Sci. 2006; 101: 344-349.
20. Jones PH, Davidson MH, Stein EA, et al. STELLAR Study Group. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial). Am J Cardiol. 2003; 92: 152-160.
21. Thum T., Tsikas D., Stein S., et al. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol. 2005; 46: 1693-1701.
22. Gerli R., Schillaci G., Giordano A., et al. CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation. 2004; 109: 2744-2748.
23. Vaudo G., Marchesi S., Gerli R., et al. Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis. 2004; 63: 31-35.
24. Llevadot J., Murasawa S., Kureishi Y., et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest. 2001; 108: 399-405.
25. Assmus B., Urbich C., Aicher A., et al. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res. 2003; 92: 1049-1055.
26. Croce G., Passacquale G., Necozione S., Ferri C., Desideri G. Nonpharmacological treatment of hypercholesterolemia increases circulating endothelial progenitor cell population in adults. Arterioscler Thromb Vasc Biol. 2006; 26: e38 - e39.
27. Werner N., Priller J., Laufs U., et al. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol. 2002; 22: 1567-1572.